Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus

BACKGROUND: Tacrolimus is the key immunosuppressive drug for liver transplantation. Once-daily prolonged-release tacrolimus (TAC-PR) exhibits good drug adherence but has difficulty controlling the trough level in the early phase of liver transplantation. The aim of this study was to compare the feas...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Yuichiro, Noda, Takehiro, Eguchi, Hidetoshi, Iwagami, Yoshifumi, Yamada, Daisaku, Asaoka, Tadafumi, Wada, Hiroshi, Kawamoto, Koichi, Gotoh, Kunihito, Takeda, Yutaka, Tanemura, Masahiro, Marubashi, Shigeru, Umeshita, Koji, Doki, Yuichiro, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585423/
https://www.ncbi.nlm.nih.gov/pubmed/28894794
http://dx.doi.org/10.1097/TXD.0000000000000722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585423/
https://www.ncbi.nlm.nih.gov/pubmed/28894794
http://dx.doi.org/10.1097/TXD.0000000000000722

Ejemplares similares